Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (513,919)	$ (433,615)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(2,752,194)	(1,555,432)
Changes in operating assets and liabilities:
Prepaid expenses	(29,090)
Account payables	533,771	200,028
Accrued expenses	604,447	497,558
Franchise tax payable	(152,379)	195,138
Income tax payable	536,212	285,662
Net cash used in operating activities	(1,773,152)	(810,661)
Cash flows from investing activities:
Cash withdrawn from Trust Account in connection with redemption	58,403,139
Interest withdraws from Trust Account for taxes	641,762
Investment of cash in Trust Account	(2,903,628)	(102,606,597)
Net cash provided by (used in) investing activities	56,141,273	(102,606,597)
Cash flows from financing activities:
Redemption of Common Stock	(58,403,139)
Proceeds from Working capital loan	754,748
Proceeds from Extension loan	2,903,628
Proceeds from sale of Units, net of IPO costs		99,429,074
Proceeds from sale of Placement Units		4,511,301
Repayment of Promissory note – related party		(133,357)
Net cash provided by (used in) financing activities	(54,744,763)	103,807,018
Net change in cash	(376,642)	389,760
Cash at the beginning of the period	391,924	2,164
Cash at the end of the period	15,282	391,924
Supplemental disclosure of non-cash investing and financing activities:
Extension Funds attributable to common stock subject to redemption	2,903,628
Remeasurement of Common Stock subject to redemption	1,445,619	1,355,432
Excise tax liability	584,031
Deferred underwriting fee payable		3,555,674
Initial Classification of Common Stock subject to redemption		102,606,597
Deferred offering costs paid for by Promissory note – related party		$ 176